Menopause Market Size, Share & Trends Analysis Report By Treatment Type (Dietary Supplements, Hormone Therapies, Non-hormonal Therapies), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Other Distribution Channels) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: February 12, 2026 | Author: Debashree B | Format: | Report Code: SR4675DR | Pages: 150

Market Segmentation

  1. Menopause Market, By Treatment Type 2022-2034 (USD MILLION/ Units)
    1. Dietary Supplements
      1. Multivitamin Supplements
      2. Phytoestrogen Supplement
      3. Antioxidant Supplements
      4. Other Supplements
    2. Hormone Therapies
      1. Progestin-only Medicines
      2. Estrogen-only Medicines
      3. Other Therapies
      4. DNA Polymerases
    3. Non-hormonal Therapies
      1. Gabapentinoids
      2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
      3. Selective Serotonin Reuptake Inhibitors (SSRI)
      4. Other Non-hormonal Therapies
  2. Menopause Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Other Distribution Channels
  3. Regional Menopause Market
    1. North America
      1. North America Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      2. North America Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
      3. U.S. Menopause Market
        1. U.S. Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. U.S. Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      4. Canada Menopause Market
        1. Canada Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Canada Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
    2. Europe
      1. Europe Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      2. Europe Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
      3. U.K. Menopause Market
        1. U.K. Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. U.K. Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      4. Germany Menopause Market
        1. Germany Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Germany Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      5. France Menopause Market
        1. France Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. France Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      6. Spain Menopause Market
        1. Spain Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Spain Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      7. Italy Menopause Market
        1. Italy Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Italy Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      8. Russia Menopause Market
        1. Russia Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Russia Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      9. Nordic Menopause Market
        1. Nordic Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Nordic Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      10. Benelux Menopause Market
        1. Benelux Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Benelux Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      11. Rest of Europe Menopause Market
        1. Rest of Europe Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Rest of Europe Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
    3. APAC
      1. APAC Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      2. APAC Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
      3. China Menopause Market
        1. China Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. China Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      4. Korea Menopause Market
        1. Korea Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Korea Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      5. Japan Menopause Market
        1. Japan Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Japan Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      6. India Menopause Market
        1. India Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. India Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      7. Australia Menopause Market
        1. Australia Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Australia Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      8. Taiwan Menopause Market
        1. Taiwan Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Taiwan Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      9. South East Asia Menopause Market
        1. South East Asia Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. South East Asia Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      10. Rest of Asia-Pacific Menopause Market
        1. Rest of Asia-Pacific Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Rest of Asia-Pacific Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
    4. Middle East and Africa
      1. Middle East and Africa Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      2. Middle East and Africa Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
      3. UAE Menopause Market
        1. UAE Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. UAE Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      4. Turkey Menopause Market
        1. Turkey Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Turkey Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      5. Saudi Arabia Menopause Market
        1. Saudi Arabia Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Saudi Arabia Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      6. South Africa Menopause Market
        1. South Africa Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. South Africa Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      7. Egypt Menopause Market
        1. Egypt Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Egypt Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      8. Nigeria Menopause Market
        1. Nigeria Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Nigeria Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      9. Rest of MEA Menopause Market
        1. Rest of MEA Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Rest of MEA Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
    5. LATAM
      1. LATAM Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Dietary Supplements
          1. Multivitamin Supplements
          2. Phytoestrogen Supplement
          3. Antioxidant Supplements
          4. Other Supplements
        2. Hormone Therapies
          1. Progestin-only Medicines
          2. Estrogen-only Medicines
          3. Other Therapies
          4. DNA Polymerases
        3. Non-hormonal Therapies
          1. Gabapentinoids
          2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
          3. Selective Serotonin Reuptake Inhibitors (SSRI)
          4. Other Non-hormonal Therapies
      2. LATAM Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other Distribution Channels
      3. Brazil Menopause Market
        1. Brazil Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Brazil Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      4. Mexico Menopause Market
        1. Mexico Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Mexico Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      5. Argentina Menopause Market
        1. Argentina Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Argentina Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      6. Chile Menopause Market
        1. Chile Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Chile Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      7. Colombia Menopause Market
        1. Colombia Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Colombia Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
      8. Rest of LATAM Menopause Market
        1. Rest of LATAM Menopause Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Dietary Supplements
            1. Multivitamin Supplements
            2. Phytoestrogen Supplement
            3. Antioxidant Supplements
            4. Other Supplements
          2. Hormone Therapies
            1. Progestin-only Medicines
            2. Estrogen-only Medicines
            3. Other Therapies
            4. DNA Polymerases
          3. Non-hormonal Therapies
            1. Gabapentinoids
            2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
            3. Selective Serotonin Reuptake Inhibitors (SSRI)
            4. Other Non-hormonal Therapies
        2. Rest of LATAM Menopause Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Hospital Pharmacies
          2. Drug Stores & Retail Pharmacies
          3. Other Distribution Channels
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: